Clinical diagnosis of dementia

Alzheimer's and Dementia

Volumn 3, Issue 4, 2007, Pages 292-298

  Robillard, Alain ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Alzheimer; Behavior; Dementia; Diagnosis; Frontotemporal; Lewy body; Vascular

Indexed keywords

ALZHEIMER DISEASE; ANAMNESIS; BEHAVIOR CHANGE; CANADA; CARDIOVASCULAR RISK; CEREBROSPINAL FLUID DRAINAGE; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITIVE DEFECT; CONSENSUS DEVELOPMENT; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; ELECTROENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; FRONTOTEMPORAL DEMENTIA; HEALTH CARE ORGANIZATION; HUMAN; LABORATORY TEST; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PERSONALITY; PHYSICAL EXAMINATION; PRIMARY PROGRESSIVE APHASIA; PRION DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SOCIAL BEHAVIOR; VISUAL HALLUCINATION;

EID: 35148821464     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.08.002     Document Type: Review

References (77)

1. Chertkow H. Introduction: the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, 2006. Alzheimers Dement 3 (2007) 262-265
2. Rockwood K., Bouchard R.W., Camicioli R., and Léger G. Toward a revision of criteria for the dementias. Alzheimers Dement 3 (2007) 428-440
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed-revised (1987), American Psychiatric Association, Washington, DC
5. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
6. O'Connor D.W., Blessed G., Cooper B., Jonker C., Morris J.C., Presnell I.B., et al. Cross-national interrater reliability of dementia diagnosis in the elderly and factors associated with disagreement. Neurology 47 (1996) 1194-1199
7. Graham J.E., Rockwood K., Beattie B.L., McDowell I., Eastwood R., and Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology 15 (1996) 246-256
8. Larson E.B., McCurry S.M., Graves A.B., Bowen J.D., Rice M.M., McCormick W.C., et al. Standardization of the clinical diagnosis of the dementia syndrome and its subtypes in a cross-sectional study: the Ni-Hon-Sea experience. J Gerontol A Biol Sci Med Sci 53A (1998) M313-M319
9. Fratiglioni L., Grut M., Forsell Y., Viitanen M., and Winblad B. Clinical diagnosis of Alzheimer's disease and other dementias in a population survey: agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, criteria. Arch Neurol 49 (1992) 927-2
10. Farrer L.A., Cupples L.A., Blackburn S., Kiely D.K., Auerbach S., Growdon J.H., et al. Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study. Neurology 44 (1994) 652-656
11. Blacker D., Albert M.S., Bassett S.S., Go R.C., Harrell L.E., and Folstein M.F. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease: the National Institute of Mental Health Genetics Initiative. Arch Neurol 51 (1994) 1198-1204
12. Lopez O.L., Litvan I., Catt K.E., Stowe R., Klunk W., Kaufer D.I., et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 53 (1999) 1292-1299
13. Lopez O.L., Becker J.T., Klunk W., Saxton J., Hamilton R.L., Kaufer D.I., et al. Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology 55 (2000) 1854-1862
14. Forette F., Henry J.F., Orgogozo J.M., et al. Reliability of clinical criteria for the diagnosis of dementia: a longitudinal multicenter study. Arch Neurol 46 (1989) 646-648
15. Holmes C., Cairns N., Lantos P., and Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174 (1999) 45-50
16. Jobst K.A., Barnetson L.P., and Shepstone B.J. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, spect, X-ray CT, and apo E4 in medial temporal lobe dementias-Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 10 (1998) 271-302
17. Lim A., Tsuang D., Kukull W., Nochlin D., Leverenz J., McCormick W., et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 47 (1999) 564-569
18. Wade J.P., Mirsen T.R., Hachinski V.C., Fisman M., Lau C., and Merskey H. The clinical diagnosis of Alzheimer's disease. Arch Neurol 44 (1987) 24-29
19. Victoroff J., Mack W.J., Lyness S.A., and Chui H.C. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 152 (1995) 1476-1484
20. Galasko D., Hansen L.A., Katzman R., Wiederholt W., Masliah E., Terry R., et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51 (1994) 888-895
21. Mayeux R., Saunders A.M., Shea S., Mirra S., Evans D., Roses A.D., et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease: Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 338 (1998) 506-511
22. Klatka L.A., Schiffer R.B., Powers J.M., and Kazee A.M. Incorrect diagnosis of Alzheimer's disease: a clinicopathologic study. Arch Neurol 53 (1997) 35-42
23. Gearing M., Mirra S.S., Hedreen J.C., Sumi S.M., Hansen L.A., and Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part X-neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45 (1995) 461-466
24. Berg L., McKeel Jr. D.W., Miller J.P., Storandt M., Rubin E.H., Morris J.C., et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55 (1998) 326-335
25. Massoud F., Devi G., Stern Y., Lawton A., Goldman J.E., Liu Y., et al. A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol 56 (1999) 1368-1373
26. Salmon D.P., Thomas R.G., Pay M.M., Booth A., Hofstetter C.R., Thal L.J., et al. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology 59 (2002) 1022-1028
27. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 (1999) 303-308
28. Petersen R.C., and Morris J.C. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62 (2005) 1160-1163
29. Petersen R.C. Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2 (2003) 646-653
30. Grundman M., Petersen R.C., Ferris S., Thomas R.G., Aisen P.S., Bennett D.A., et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61 (2004) 59-66
31. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., et al. Vitamin E and donepezil in the treatment of mild cognitive impairment. N Engl J Med 352 (2005) 2379-2388
32. Chertkow H., Nasreddine Z., Joanette Y., Drolet V., Kirk J., Massoud F., et al. Mild cognitive impairment and cognitive impairment, no dementia: part A, concept and diagnosis. Alzheimers Dement 3 (2007) 266-282
33. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53 (2005) 695-699
34. Rockwood K., Davis H., MacKnight C., Vandorpe R., Gauthier S., Guzman A., et al. The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. Can J Neurol Sci 30 (2003) 237-243
35. Gold G., Giannakopoulos P., Montes-Paixao Junior C., et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 49 (1997) 690-694
36. Gold G., Bouras C., Canuto A., Bergallo Herrmenn F.R., Hof P., Mayor P.A., et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 159 (2002) 82-87
37. Pohjasvaara T., Mantyla R., Ylikoski R., Kaste M., and Erkinjuntti T. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10,NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. Stroke 31 (2000) 2952-2957
38. Cosentino S.A., Jefferson A.L., Carey M., Price C.C., Davis-Garrett K., Swenson R., et al. The clinical diagnosis of vascular dementia: a comparison among four classification systems and a proposal for a new paradigm. Clin Neuropsychol 18 (2004) 6-21
39. Chui H.C., Mack W., Jackson J.E., Mungas D., Reed B.R., Tinklenberg J., et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol 57 (2000) 191-196
40. Graham N.L., Emery T., and Hodges J.R. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 75 (2004) 61-71
41. Tierney M.C., Black S.E., Szalai J.P., Snow W.G., Fisher R.H., Nadon G., et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol 58 (2001) 1654-1659
42. McKeith G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65 (2005) 1863-1872
43. Noe E., Marder K., Bell K.L., Jacobs D.M., Manly J.J., and Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord 19 (2004) 60-67
44. Litvan I., Bhatia K.P., Burn D.J., Goetz C.G., Lang A.E., McKeith I., et al. SIC Task Force Appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 18 (2003) 467-486
45. Kosaka K. Lewy bodies in cerebral cortex: report of three cases. Acta Neuropathol 42 (1978) 127-134
46. Kosaka K., Yoshimura M., Ikeda K., and Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: a new disease?. Clin Neuropathol 3 (1984) 185-192
47. Litvan I., MacIntyre A., Goetz C.G., Wenning G.K., Jellinger K., Verny M., et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55 (1998) 969-978
48. Luis C.A., Barker W.W., Gajaraj K., Harwood D., Petersen R., Kashuba A., et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 14 (1999) 526-533
49. Mega M.S., Masterman D.L., Benson D.F., and Vinters H.V. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 47 (1996) 1403-1409
50. Verghese J., Crystal H.A., Dickson D.W., and Lipton R.B. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 53 (1999) 1974-1982
51. Lopez O.L., Becker J.T., Kaufer D., Hamilton R., Sweet R., Klunk W., et al. Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch Neurol 59 (2002) 43-46
52. Lopez O.L., Hamilton R.L., Becker J.T., Wisniewski S., Kaufer D.I., and DeKosky S.T. Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 54 (2000) 1780-1787
53. Del Ser T., Hachinski V., Merskey H., and Munoz D.G. Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load. Alzheimer Dis Assoc Disord 15 (2001) 31-44
54. Merdes A.R., Hansen L.A., Jeste D.V., Galasko D., Hofstetter C.R., Ho G.J., et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 60 (2003) 1586-1590
55. Hodges J.R. Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology 56 Suppl 4 (2001) S6-S10
56. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57 (1994) 416-418
57. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51 (1998) 1546-1554
58. Varma A.R., Snowden J.S., Lloyd J.J., Talbot P.R., Mann D.M., and Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66 (1999) 184-188
59. Miller B.L., Ikonte C., Ponton M., Levy M., Boone K., Darby A., et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 48 (1997) 937-942
60. Josephs K.A., Petersen R.C., Knopman D.S., Boeve B.F., Whitwell J.L., Duffy J.R., et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66 (2006) 41-48
61. Hakim S., and Adams R.D. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure: observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2 (1965) 307-327
62. Vanneste J.A. Three decades of normal pressure hydrocephalus: are we wiser now?. J Neurol Neurosurg Psychiatry 57 (1994) 1021-1025
63. Vanneste J., Augustijn P., Dirven C., Tan W.F., and Goedhart Z.D. Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks?. Neurology 42 (1992) 54-58
64. Walchenbach G.E., Thomeer R.T., and Vanneste J.A. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 72 (2002) 503-506
65. Silverberg G.D., Mayo M., Saul T., Rubenstein E., and McGuire D. Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2 (2003) 506-511
66. Silverberg G.D., Heit G., Huhn S., Jaffe R.A., Chang S.D., Bronte-Stewart H., et al. CSF production is reduced in dementia of the Alzheimer's type. Neurology 57 (2001) 1763-1766
67. Silverberg G.D., Levinthal E., Sullivan E.V., Bloch D.A., Chang S.D., Leverenz J., et al. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 59 (2002) 1139-1145
68. Masters C.L., Harris J.O., Gajdusek D.C., Gibbs Jr. C.J., Bernoulli C., and Asher D.M. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5 (1979) 177-188
69. Cathala F., Brown P., Castaigne P., and Gajdusek D.C. La maladie de Creutzfeldt-Jakob en France continentale: etude rétrospective de 1968-1977. Rev Neurol 5 (1979) 439-454
70. Concerted action of the EU. Surveillance of Creutzfeldt-Jakob disease in the European community: minutes of the second meeting in Rome, July 3, 1993, and the third meeting in Paris, April 29-30 (1994)
71. Poser S., Mollenhauer B., Kraubeta A., Zerr I., Steinhoff B.J., Schroeter A., et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 122 (1999) 2345-2351
72. Brandel J.P., Delasnerie-Laupretre N., Laplanche J.L., Hauw J.J., and Alperovitch A. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology 54 (2000) 1095-1099
73. Hsich G., Kenney K., Gibbs C.J., Lee K.H., and Harrington M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335 (1996) 924-930
74. Burkhard P.R., Sanchez J.C., Landis T., and Hochstrasser D. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 56 (1997) 1528-1533
75. Castellani R.J., Colucci M., Xie Z., Zou W., Li C., Parchi P., et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 63 (2004) 436-442
76. Shiga Y., Miyazawa K., Sato S., Fukushima R., Shibuya S., Sato Y., et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 63 (2004) 443-449
77. Meissner B., Köhler K., Körtner K., Bartl M., Jastrow U., Mollenhauer B., et al. Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology 63 (2004) 450-456